Compare ACIU & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACIU | CPSS |
|---|---|---|
| Founded | 2003 | 1991 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 201.5M |
| IPO Year | 2016 | 1992 |
| Metric | ACIU | CPSS |
|---|---|---|
| Price | $3.68 | $9.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 21.3K |
| Earning Date | 11-04-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | $5,482,957.00 | ★ $196,531,000.00 |
| Revenue This Year | N/A | $139.62 |
| Revenue Next Year | $644.42 | $10.58 |
| P/E Ratio | ★ N/A | $11.04 |
| Revenue Growth | N/A | ★ 6.67 |
| 52 Week Low | $1.43 | $6.67 |
| 52 Week High | $4.00 | $12.73 |
| Indicator | ACIU | CPSS |
|---|---|---|
| Relative Strength Index (RSI) | 64.73 | 50.63 |
| Support Level | $3.09 | $9.07 |
| Resistance Level | $3.73 | $9.44 |
| Average True Range (ATR) | 0.21 | 0.22 |
| MACD | 0.06 | -0.08 |
| Stochastic Oscillator | 91.86 | 35.10 |
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.